📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

MEK1/2 inhibition decreases lactate in BRAF-driven human cancer cells. (2013)

First Author: Falck Miniotis M

Attributed to: Multimodality Techniques for Cancer Diagnosis and Therapy funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1158/0008-5472.can-12-1969

PubMed Identifier: 23639941

Publication URI: http://europepmc.org/abstract/MED/23639941

Type: Journal Article/Review

Volume: 73

Parent Publication: Cancer research

Issue: 13

ISSN: 0008-5472